Vitale, Ilio
Manic, Gwenola
Galluzzi, Lorenzo
Article History
Received: 15 January 2021
Revised: 22 January 2021
Accepted: 25 January 2021
First Online: 11 February 2021
Conflict of interest
: L.G. reports research funding from Lytix, and Phosplatin (completed), consulting/advisory honoraria from Boehringer Ingelheim, AstraZeneca, OmniSEQ, The Longevity Labs, Inzen, and the Luke Heller TECPR2 Foundation.
: For this type of paper formal consent is not required. This paper does not contain any studies with human participants or animals performed by any of the authors.